Information on Organism Streptomyces peucetius

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(4R)-carvone biosynthesis

-

PWY-5928

(5Z)-dodecenoate biosynthesis I

-

PWY0-862

(5Z)-dodecenoate biosynthesis II

-

PWY-7858

(S)-reticuline biosynthesis

-

1,3-propanediol biosynthesis (engineered)

-

PWY-7385

1,5-anhydrofructose degradation

-

PWY-6992

11-oxyandrogens biosynthesis

-

PWY-8202

2'-deoxymugineic acid phytosiderophore biosynthesis

-

PWY-5912

2-oxoglutarate decarboxylation to succinyl-CoA

-

PWY-5084

2-oxoisovalerate decarboxylation to isobutanoyl-CoA

-

PWY-5046

24-epi-campesterol, fucosterol, and clionasterol biosynthesis (diatoms)

-

PWY-8238

8-amino-7-oxononanoate biosynthesis I

-

PWY-6519

Acarbose and validamycin biosynthesis

-

00525

-

acetone degradation I (to methylglyoxal)

-

PWY-5451

acetone degradation III (to propane-1,2-diol)

-

PWY-7466

acetyl CoA biosynthesis

-

aclacinomycin biosynthesis

Aflatoxin biosynthesis

-

00254

-

all-trans-farnesol biosynthesis

-

PWY-6859

Amaryllidacea alkaloids biosynthesis

-

PWY-7826

Amino sugar and nucleotide sugar metabolism

-

00520

-

Aminobenzoate degradation

-

00627

-

androgen and estrogen metabolism

-

arachidonate biosynthesis

-

Arachidonic acid metabolism

-

00590

-

arachidonic acid metabolism

-

arsenic detoxification (plants)

-

PWY-8259

arsenic detoxification (yeast)

-

PWY-4621

avenanthramide biosynthesis

-

PWY-8157

Betalain biosynthesis

-

00965

-

Bifidobacterium shunt

-

P124-PWY

Biosynthesis of 12-, 14- and 16-membered macrolides

-

00522

-

Biosynthesis of secondary metabolites

-

01110

-

Biosynthesis of siderophore group nonribosomal peptides

-

01053

-

Biosynthesis of type II polyketide backbone

-

01056

-

Biosynthesis of type II polyketide products

-

01057

-

Biosynthesis of vancomycin group antibiotics

-

01055

-

Biotin metabolism

-

00780

-

bisabolene biosynthesis (engineered)

-

PWY-7102

bupropion degradation

-

PWY66-241

Caffeine metabolism

-

00232

-

capsaicin biosynthesis

-

PWY-5710

Carbon fixation pathways in prokaryotes

-

00720

-

chitin degradation I (archaea)

-

PWY-6855

chitin degradation II (Vibrio)

-

PWY-6902

chitin degradation III (Serratia)

-

PWY-7822

chlorogenic acid biosynthesis I

-

PWY-6039

cholesterol biosynthesis

-

cholesterol biosynthesis (algae, late side-chain reductase)

-

PWY-8191

cholesterol biosynthesis (diatoms)

-

PWY-8239

cholesterol biosynthesis (plants, early side-chain reductase)

-

PWY18C3-1

cholesterol biosynthesis II (via 24,25-dihydrolanosterol)

-

PWY66-3

Citrate cycle (TCA cycle)

-

00020

-

citric acid cycle

-

CO2 fixation in Crenarchaeota

-

coenzyme A biosynthesis I (bacteria)

-

COA-PWY

coenzyme A biosynthesis II (eukaryotic)

-

PWY-7851

coenzyme A metabolism

-

coumarins biosynthesis (engineered)

-

PWY-7398

curcuminoid biosynthesis

-

PWY-6432

Cysteine and methionine metabolism

-

00270

-

daunorubicin biosynthesis

diploterol biosynthesis

-

PWY-6098

doxorubicin biosynthesis

-

PWY-7355

Drug metabolism - cytochrome P450

-

00982

-

dTDP-3-acetamido-3,6-dideoxy-alpha-D-glucose biosynthesis

-

PWY-7318

dTDP-3-acetamido-alpha-D-fucose biosynthesis

-

PWY-6953

dTDP-4-O-demethyl-beta-L-noviose biosynthesis

-

PWY-7301

dTDP-6-deoxy-alpha-D-allose biosynthesis

-

PWY-7413

dTDP-alpha-D-forosamine biosynthesis

-

PWY-6808

dTDP-alpha-D-mycaminose biosynthesis

-

PWY-7414

dTDP-alpha-D-olivose, dTDP-alpha-D-oliose and dTDP-alpha-D-mycarose biosynthesis

-

PWY-6973

dTDP-alpha-D-ravidosamine and dTDP-4-acetyl-alpha-D-ravidosamine biosynthesis

-

PWY-7688

dTDP-beta-D-fucofuranose biosynthesis

-

PWY-7312

dTDP-beta-L-4-epi-vancosamine biosynthesis

-

PWY-7440

dTDP-beta-L-digitoxose biosynthesis

-

PWY-7657

dTDP-beta-L-megosamine biosynthesis

-

PWY-7104

dTDP-beta-L-mycarose biosynthesis

-

PWY-6976

dTDP-beta-L-olivose biosynthesis

-

PWY-6974

dTDP-beta-L-rhamnose biosynthesis

-

DTDPRHAMSYN-PWY

dTDP-D-desosamine biosynthesis

-

PWY-6942

dTDP-L-daunosamine biosynthesis

-

PWY-7814

dTDP-N-acetylthomosamine biosynthesis

-

PWY-7315

dTDP-N-acetylviosamine biosynthesis

-

PWY-7316

dTDP-sibirosamine biosynthesis

-

PWY-8380

dTDPLrhamnose biosynthesis

-

elloramycin biosynthesis

-

ergosterol biosynthesis II

-

PWY-7154

erythromycin D biosynthesis

-

PWY-7106

ethene biosynthesis I (plants)

-

ETHYL-PWY

ethene biosynthesis III (microbes)

-

PWY-6854

Fatty acid biosynthesis

-

00061

-

fatty acid biosynthesis initiation (mitochondria)

-

PWY66-429

fatty acid biosynthesis initiation (type I)

-

PWY-5966-1

fatty acid biosynthesis initiation (type II)

-

PWY-4381

Fatty acid degradation

-

00071

-

fatty acid elongation -- saturated

-

FASYN-ELONG-PWY

firefly bioluminescence

-

PWY-7913

flaviolin dimer and mompain biosynthesis

-

PWY-7513

Flavonoid biosynthesis

-

00941

-

Folate biosynthesis

-

00790

-

Galactose metabolism

-

00052

-

GDP-alpha-D-glucose biosynthesis

-

PWY-5661

geosmin biosynthesis

-

PWY-5950

glucocorticoid biosynthesis

-

PWY66-381

glucose and glucose-1-phosphate degradation

-

GLUCOSE1PMETAB-PWY

glutathione-mediated detoxification I

-

PWY-4061

glutathione-mediated detoxification II

-

PWY-6842

Glycerolipid metabolism

-

00561

-

glycine biosynthesis II

-

GLYCINE-SYN2-PWY

glycine cleavage

-

GLYCLEAV-PWY

Glycine, serine and threonine metabolism

-

00260

-

glycogen degradation I

-

GLYCOCAT-PWY

glycogen degradation II

-

PWY-5941

glycogen metabolism

-

Glycolysis / Gluconeogenesis

-

00010

-

glycolysis I (from glucose 6-phosphate)

-

GLYCOLYSIS

glycolysis III (from glucose)

-

ANAGLYCOLYSIS-PWY

Glycosaminoglycan degradation

-

00531

-

Glycosphingolipid biosynthesis - ganglio series

-

00604

-

Glyoxylate and dicarboxylate metabolism

-

00630

-

gondoate biosynthesis (anaerobic)

-

PWY-7663

gossypetin metabolism

-

PWY-7495

gossypol biosynthesis

-

PWY-5773

heterolactic fermentation

-

P122-PWY

hopanoid biosynthesis (bacteria)

-

PWY-7072

isoprene biosynthesis II (engineered)

-

PWY-7391

isoprenoid biosynthesis

-

Isoquinoline alkaloid biosynthesis

-

00950

-

jadomycin biosynthesis

-

PWY-6679

L-dopa and L-dopachrome biosynthesis

-

PWY-6481

L-methionine degradation I (to L-homocysteine)

-

METHIONINE-DEG1-PWY

lacinilene C biosynthesis

-

PWY-5828

Limonene and pinene degradation

-

00903

-

Linoleic acid metabolism

-

00591

-

lipid A biosynthesis

-

lipid A-core biosynthesis (E. coli K-12)

-

LIPA-CORESYN-PWY

lipid metabolism

-

Lysine degradation

-

00310

-

macrolide antibiotic biosynthesis

-

melatonin degradation I

-

PWY-6398

Metabolic pathways

-

01100

-

metabolism of disaccharids

-

Metabolism of xenobiotics by cytochrome P450

-

00980

-

methionine metabolism

-

methylaspartate cycle

-

methylerythritol phosphate pathway I

-

NONMEVIPP-PWY

methylerythritol phosphate pathway II

-

PWY-7560

methymycin, neomethymycin and novamethymycin biosynthesis

-

PWY-7422

mevalonate metabolism

-

mevalonate pathway I (eukaryotes and bacteria)

-

PWY-922

mevalonate pathway II (haloarchaea)

-

PWY-6174

mevalonate pathway III (Thermoplasma)

-

PWY-7524

mevalonate pathway IV (archaea)

-

PWY-8125

Microbial metabolism in diverse environments

-

01120

-

mineralocorticoid biosynthesis

-

PWY66-382

mono-trans, poly-cis decaprenyl phosphate biosynthesis

-

PWY-6383

Monoterpenoid biosynthesis

-

00902

-

mycolate biosynthesis

-

PWYG-321

narbomycin, pikromycin and novapikromycin biosynthesis

-

PWY-7421

Neomycin, kanamycin and gentamicin biosynthesis

-

00524

-

nicotine degradation IV

-

PWY66-201

nicotine degradation V

-

PWY66-221

non-pathway related

-

O-Antigen nucleotide sugar biosynthesis

-

00541

-

octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast)

-

PWY-7388

oleandomycin activation/inactivation

-

PWY-6972

oleate biosynthesis IV (anaerobic)

-

PWY-7664

Other glycan degradation

-

00511

-

oxidative decarboxylation of pyruvate

-

palmitate biosynthesis

-

palmitate biosynthesis II (type II fatty acid synthase)

-

PWY-5971

palmitate biosynthesis III

-

PWY-8279

palmitoleate biosynthesis I (from (5Z)-dodec-5-enoate)

-

PWY-6282

Pantothenate and CoA biosynthesis

-

00770

-

phenylpropanoid biosynthesis

-

PWY-361

Phenylpropanoid biosynthesis

-

00940

-

phenylpropanoid biosynthesis

-

phenylpropanoids methylation (ice plant)

-

PWY-7498

pheomelanin biosynthesis

-

PWY-7917

phosphopantothenate biosynthesis I

-

PANTO-PWY

phosphopantothenate biosynthesis II

-

PWY-3961

photosynthesis

-

phytosterol biosynthesis (plants)

-

PWY-2541

Polyketide sugar unit biosynthesis

-

00523

-

Porphyrin and chlorophyll metabolism

-

00860

-

Propanoate metabolism

-

00640

-

pyridoxal 5'-phosphate biosynthesis I

-

PYRIDOXSYN-PWY

pyruvate decarboxylation to acetyl CoA I

-

PYRUVDEHYD-PWY

Pyruvate metabolism

-

00620

-

reactive oxygen species degradation

-

DETOX1-PWY-1

retinol biosynthesis

-

PWY-6857

Retinol metabolism

-

00830

-

S-(6-hydroxy-4-methylhexan-4-yl)-L-cysteinylglycine biosynthesis

-

PWY-8301

S-adenosyl-L-methionine biosynthesis

-

SAM-PWY

S-adenosyl-L-methionine salvage I

-

PWY-6151

S-adenosyl-L-methionine salvage II

-

PWY-5041

saframycin A biosynthesis

-

PWY-7671

scopoletin biosynthesis

-

PWY-6792

Sesquiterpenoid and triterpenoid biosynthesis

-

00909

-

Sphingolipid metabolism

-

00600

-

Starch and sucrose metabolism

-

00500

-

stearate biosynthesis II (bacteria and plants)

-

PWY-5989

stearate biosynthesis IV

-

PWY-8280

Steroid biosynthesis

-

00100

-

Steroid hormone biosynthesis

-

00140

-

Stilbenoid, diarylheptanoid and gingerol biosynthesis

-

00945

-

Streptomycin biosynthesis

-

00521

-

streptorubin B biosynthesis

-

PWY1A0-6120

suberin monomers biosynthesis

sucrose biosynthesis II

-

PWY-7238

sucrose degradation II (sucrose synthase)

-

PWY-3801

sucrose degradation III (sucrose invertase)

-

PWY-621

superoxide radicals degradation

-

DETOX1-PWY

superpathway of coenzyme A biosynthesis III (mammals)

-

COA-PWY-1

superpathway of fatty acid biosynthesis initiation

-

FASYN-INITIAL-PWY

taurine biosynthesis I

-

PWY-5331

taurine biosynthesis II

-

PWY-7850

Terpenoid backbone biosynthesis

-

00900

-

tetradecanoate biosynthesis (mitochondria)

-

PWY66-430

Thiamine metabolism

-

00730

-

thiazole component of thiamine diphosphate biosynthesis I

-

PWY-6892

thiazole component of thiamine diphosphate biosynthesis II

-

PWY-6891

trehalose degradation I (low osmolarity)

-

TREDEGLOW-PWY

trehalose degradation II (cytosolic)

-

PWY0-1182

trehalose degradation IV

-

PWY-2722

trehalose degradation V

-

PWY-2723

triacylglycerol degradation

-

LIPAS-PWY

Tryptophan metabolism

-

00380

-

Tyrosine metabolism

-

00350

-

UDP-N-acetyl-D-galactosamine biosynthesis II

-

PWY-5514

UDP-N-acetyl-D-glucosamine biosynthesis II

-

UDPNACETYLGALSYN-PWY

Valine, leucine and isoleucine degradation

-

00280

-

vanillin biosynthesis I

-

PWY-5665

vitamin B1 metabolism

-

xyloglucan degradation II (exoglucanase)

-

PWY-6807

zymosterol biosynthesis

-

PWY-6074

Streptomyces peucetius

10 entries

cell culture

Streptomyces peucetius

B0FLN6

strain ATCC 27952 produces clinically important anthracycline chemotherapeutic agents of the polyketide class of antibiotics, daunorubicin and doxorubicin

693594

mycelium

Streptomyces peucetius

C5J048, O33707

-

726772

membrane

Streptomyces peucetius

B1PT66

-

16020

702829

NCBI: Taxonomy, PubMed, Genome

SILVA: 16S/18S rRNA, 23S/28S rRNA

: 157525